FDA Approves OTC Glucometer For iPhone To Monitor Blood Sugar Levels
However, this freedom does have some caveats. FDA Approves Dexcom’s Stelo Glucose Biosensor System As An OTC Glucometer The ...
pharmaphorum21 小时
FDA clears first OTC glucose biosensor, from Dexcom
The FDA has cleared Dexcom’s Stelo as the first continuous glucose ... and now is creating a new category by bringing the first glucose biosensor cleared for use over-the-counter,” said ...
来自MSN1 年
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
The Dexcom Stelo Glucose Biosensor System is an integrated CGM (iCGM) intended for anyone 18 years and older who does not use insulin. The company said Stelo will be available online without a ...
pharmaphorum2 天
Abbott’s OTC glucose monitor ‘will grow the market’
Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...
Nasdaq22 天
DexCom: Revenue Up, EPS Misses Mark
DexCom (NASDAQ:DXCM), known for its continuous glucose monitoring ... the introduction of their G7 system and further development of offerings like the Dexcom Stelo, targeting non-insulin-using ...
health.economictimes.indiatimes22 天
Dexcom beats fourth-quarter sales, reiterates 2025 revenue forecast
Bengaluru: Medical device maker Dexcom beat fourth-quarter sales estimates helped by resilient demand for its continuous glucose monitors ... is pinning its hopes on Stelo, its recently launched ...